ArticlebioRxiv : the preprint server for biology2026
IntegrateRigor: annotation-free integration optimization for cell identity recovery reveals cancer-immune interface niches.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Integrating single-cell and spatial transcriptomics data across batches is essential for recovering comparable cell identities-including cell types, subtypes, and states-as a prerequisite for downstream analyses in multi-condition and large-scale studies. This task remains challenging because between-batch variation removal often conflicts with cell identity preservation, and current methods typically rely on generic highly variable gene selection and lack principled metrics for hyperparameter tuning when cell identity annotations are unavailable. Together, these limitations often lead to over-integration, which merges biologically distinct cell identities, or under-integration, which leaves cells separated by batch rather than identity. Here we introduce IntegrateRigor, a data-driven, annotation-free, method-agnostic framework that optimizes integration specifically for reliable cell identity recovery across batches. IntegrateRigor first selects genes whose expression patterns are stable across batches using a gene-wise likelihood-based batch stability score, excluding batch-sensitive genes that can bias cell identity alignment during integration. It then identifies the optimal integration configuration across methods and hyperparameters by defining a dataset-level integration score that explicitly balances between-batch variation removal against cell identity preservation, without requiring prior annotations. In a colorectal cancer single-cell and spatial transcriptomics dataset, IntegrateRigor revealed previously uncharacterized cancer-immune interface niches in the tumor microenvironment that were masked by under-integration under default settings and by over-integration in previous literature. Across diverse datasets spanning multiple sources of between-batch variation, IntegrateRigor consistently improved cell identity recovery by mitigating both over-integration and under-integration across five state-of-the-art integration methods. By transforming integration from a heuristic preprocessing step into a statistically principled, dataset-adaptive procedure for cell identity recovery, IntegrateRigor improves the reproducibility and biological discovery power of large-scale single-cell and spatial transcriptomics analyses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.